Poly--Glutamic Acid Attenuates Angiogenesis and Inflammation in Experimental Colitis
Figure 3
Angiogenesis in a γ-PGA-treated DSS-induced colitis model. (a) Colonic microvasculature stained for endothelial cells (200x magnification) using the CD31 antibody. Control group (without DSS; Cont), 3% DSS administration group (DSS), 3% DSS with γ-PGA at 50 mg/kg body weight per day (D + P50), 3% DSS with γ-PGA at 200 mg/kg body weight per day (D + P200). (b) Analysis of the area densities of blood vessels. Bars represent the mean ± SD from 3 slides per mouse. *, DSS versus Cont; #, D + P50 and D + P200 versus DSS.
